Multiples measured against the stock's own five-year history
Above its usual level · 68th percentile, 5-year average 27.7x
#2684 of 2973 stocks by PE (1 = cheapest)
Below its usual level · 37th percentile, 5-year average 2.1x
#2362 of 5317 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 19th percentile, 5-year average 2.5x
#1953 of 5146 stocks by PS (1 = cheapest)
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 1.49 | – | 2.08 | 37% (cheaper than usual) | #2362 of 5317 (1 = cheapest) |
| PE | 72.00 | 25.43 | 27.74 | 68% (pricier than usual) | #2684 of 2973 (1 = cheapest) |
| PS | 1.35 | 1.33 | 2.50 | 19% (cheaper than usual) | #1953 of 5146 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on PCRX.